Jan 29, 2024 Implementation deadlines for the EU In Vitro Diagnostic Medical Device Regulation further postponed By Alex Denoon Melissa Dix Extending the transitional periods for implementation A considerable number of in vitro diagnostic medical devices (IVDs) currently on...
Jan 26, 2024 Irides: Weekly patent litigation update By Dominic Adair Andrew Bowler Claire Phipps-Jones The Irides Weekly Update is our round-up of patent litigation news highlights from around the world. Taking its name from the plural of...
Jan 25, 2024 Employee wellbeing - Flexible working By Emily Atkinson In this fourth article in our wellbeing series we’re covering flexible working. The flexibility of an employer’s approach to how, where...
Jan 25, 2024 Thatchers' trade mark and passing off claim against Aldi goes down in a cloud of cider By Sean Ibbetson Somerset-based cider maker Thatchers yesterday lost its trade mark infringement and passing off claim against the discount retailer Aldi....
Jan 23, 2024 New gateway to the UPC: Irish referendum to be held 6th-9th June 2024 By Eden Winlow Irish Enterprise Minister Simon Coveney has today gained Cabinet permission to draft the bill for the Unified Patent Court (UPC)...
Jan 23, 2024 UK MDR: further delays, unexpected developments? By Alex Denoon Jamie Hatzel On 9 January 2024, the MHRA published a new Regulatory Roadmap, which sets out the expected timeline and key milestones on the way to the...
Jan 19, 2024 Irides: Weekly patent litigation update By Dominic Adair Claire Phipps-Jones The Irides Weekly Update is our round-up of patent litigation news highlights from around the world. Taking its name from the plural of...
Jan 18, 2024 Biotech settlement agreements – a competition law checklist By Sophie Lawrance Sean-Paul Brankin This article is part of our Biotech Review of the Year - Issue 11 publication Introduction The European Commission (EC) published its...
Jan 18, 2024 Strategic considerations for partnering with CDMOs for cell and gene therapies By Claire Smith Erik Müürsepp This article is part of our Biotech Review of the Year - Issue 11 publication The biopharmaceutical landscape is undergoing a steady but...
Jan 18, 2024 Royalty monetisation – why some biotechs are turning to royalty aggregators to help unlock the future value of their out-licensed technology By Marek Petecki Ellen Lambrix This article is part of our Biotech Review of the Year - Issue 11 publication Ellen Lambrix and Marek Petecki in conversation with Brad...
Jan 18, 2024 The UK Government’s Autumn 2023 Statement – support for life sciences By Julia Cockroft Nick Cross This article is part of our Biotech Review of the Year - Issue 11 publication The UK Government has announced significant investment...
Jan 18, 2024 The application of G2/21 by the Court of Appeal By Adrian Chew Jonathan Ross This article is part of our Biotech Review of the Year - Issue 11 publication On 4 May 2023, the Court of Appeal, with the leading...